Microba Life Sciences (ASX:MAP) Interest Expense : A$-0.07 Mil (TTM As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Microba Life Sciences Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Microba Life Sciences's interest expense for the six months ended in Dec. 2024 was A$ -0.08 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2024 was A$-0.07 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Microba Life Sciences's Operating Income for the six months ended in Dec. 2024 was A$ -11.01 Mil. Microba Life Sciences's Interest Expense for the six months ended in Dec. 2024 was A$ -0.08 Mil. Microba Life Sciences did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Microba Life Sciences Interest Expense Historical Data

The historical data trend for Microba Life Sciences's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microba Life Sciences Interest Expense Chart

Microba Life Sciences Annual Data

Trend

Jun22

Jun23

Jun24

Interest Expense

-0.01

-0.02

Microba Life Sciences Semi-Annual Data
	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Interest Expense	Get a 7-Day Free Trial			-0.03	0.01	-0.03	0.01	-0.08

Microba Life Sciences Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$-0.07 Mil.

Microba Life Sciences (ASX:MAP) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Microba Life Sciences's Interest Expense for the six months ended in Dec. 2024 was A$-0.08 Mil. Its Operating Income for the six months ended in Dec. 2024 was A$-11.01 Mil. And its Long-Term Debt & Capital Lease Obligation for the six months ended in Dec. 2024 was A$1.94 Mil.

Microba Life Sciences's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Microba Life Sciences did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Microba Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Microba Life Sciences Ltd (ASX:MAP) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

324 Queen Street, Level 10, Brisbane, QLD, AUS, 4000

Website

https://www.microba.com

Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome and engages in providing gut microbiome testing services globally to consumers, clinicians, and researchers. It is also involved in developing new pathology services, therapeutics, and diagnostics based on the human gut microbiome. The company's operating segments are; Testing Services and Supplements which derives key revenue, and Research and Development. Geographically, the company derives maximum revenue from Australia and the rest from Europe, New Zealand, the United States, Asia, and other regions.

Microba Life Sciences Headlines

No Headlines